Appili Therapeutics doses first patients in Covid-19 clinical trial
Canada-based Appili Therapeutics has enrolled and dosed the first cluster of participants in its Phase...
MediPharm begins trial of cannabis-derived products for kidney disease
Canada-based MediPharm Labs has begun a clinical trial to research and analyse the effectiveness of...
Revive Therapeutics expands Phase III Covid-19 trial of Bucillamine
Revive Therapeutics is set to expand the Phase III clinical trial of Bucillamine as a...
IMV receives funding for trials of its Covid-19 vaccine candidate
Clinical-stage biopharmaceutical company IMV has announced that the government agencies of Canada will invest up...
Dosing begins in Phase I trial of Medicago’s Covid-19 vaccine
Dynavax Technologies has announced the commencement of dosing in a Phase I clinical trial of...
IQVIA and LMC Manna Research to launch Prime Site in Canada
IQVIA has entered a strategic alliance with LMC Manna Research to launch its first Prime...
Montreal Heart Institute to continue COLCORONA study
Montreal Heart Institute in Canada has said that the COLCORONA clinical study, assessing colchicine, will...
Revive seeks approval to test Bucillamine for Covid-19
Revive Therapeutics has submitted a clinical trial application to Health Canada to conduct a Phase...
Health Canada approves first Covid-19 vaccine trials
The Canadian Center for Vaccinology (CCfV) at Dalhousie University has received approval from Health Canada...
Appili Therapeutics submits clinical trial application with Health Canada
Anti-infective drug development-focused biopharmaceutical firm Appili Therapeutics has filed a clinical trial application (CTA) with...